saikosaponin d has been researched along with Autoimmune Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, TT; Sun, Y; Xu, Q; Zhou, XB | 1 |
| Fan, LY; Pan, HF; Wu, GC; Wu, H | 1 |
1 review(s) available for saikosaponin d and Autoimmune Disease
| Article | Year |
|---|---|
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
Topics: Animals; Autoimmune Diseases; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Oleanolic Acid; Saponins | 2011 |
1 other study(ies) available for saikosaponin d and Autoimmune Disease
| Article | Year |
|---|---|
Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis.
Topics: Animals; Apoptosis; Autoimmune Diseases; Bupleurum; Cell Cycle; Cell Proliferation; Cyclin D3; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytochromes c; Dose-Response Relationship, Drug; Down-Regulation; Female; Immunosuppression Therapy; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Oleanolic Acid; Saponins; T-Lymphocytes; Tumor Necrosis Factor-alpha; Up-Regulation | 2009 |